Skip to main content
. 2009 Jan 1;27(1):38–44. doi: 10.1200/JCO.2008.17.1777

Fig 1.

Fig 1.

(A) Overall survival for E1694 patients (n = 670) with baseline S100B level of ≥ 0.15 μg/L (high) compared with less than 0.15 μg/L (normal). (B) Recurrence-free survival for E1694 patients (n = 667) with baseline S100B level of ≥ 0.15 μg/L (high) compared with less than 0.15 μg/L (normal).